Table of Contents
International Journal of Molecular Imaging
Volume 2012 (2012), Article ID 434790, 8 pages
http://dx.doi.org/10.1155/2012/434790
Clinical Study

Renal Function in Relation to Cardiac 123I-MIBG Scintigraphy in Patients with Chronic Heart Failure

1Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Oosterpark 9, 1091 AC Amsterdam, The Netherlands
2Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
3Cardiology Centres of the Netherlands, IJsbaanpad 10 C, 1076 CV Amsterdam, The Netherlands

Received 25 October 2011; Accepted 13 February 2012

Academic Editor: Darrell R. Fisher

Copyright © 2012 Derk O. Verschure et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. J. Verberne, L. M. Brewster, G. A. Somsen, and B. L. F. Van Eck-Smit, “Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review,” European Heart Journal, vol. 29, no. 9, pp. 1147–1159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. F. Jacobson, R. Senior, M. D. Cerqueira et al., “Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study,” Journal of the American College of Cardiology, vol. 55, no. 20, pp. 2212–2221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. H. L. Hillege, D. Nitsch, M. A. Pfeffer et al., “Renal function as a predictor of outcome in a broad spectrum of patients with heart failure,” Circulation, vol. 113, no. 5, pp. 671–678, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Ljungman, J. Kjekshus, and K. Swedberg, “Renal function in severe congestive heart failure during treatment with Enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] trial),” American Journal of Cardiology, vol. 70, no. 4, pp. 479–487, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. D. L. Dries, D. V. Exner, M. J. Domanski, B. Greenberg, and L. W. Stevenson, “The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction,” Journal of the American College of Cardiology, vol. 35, no. 3, pp. 681–689, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Kurata, Y. Wakabayashi, S. Shouda et al., “Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure,” Journal of Nuclear Medicine, vol. 36, no. 11, pp. 2037–2043, 1995. View at Google Scholar · View at Scopus
  7. T. Furuhashi and M. Moroi, “Importance of renal function on prognostic value of cardiac iodine-123 metaiodobenzylguanidine scintigraphy,” Annals of Nuclear Medicine, vol. 21, no. 1, pp. 57–63, 2007. View at Google Scholar · View at Scopus
  8. G. F. Dibona and U. C. Kopp, “Neural control of renal function,” Physiological Reviews, vol. 77, no. 1, pp. 75–197, 1997. View at Google Scholar · View at Scopus
  9. V. Kon, A. Yared, and I. Ichikawa, “Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion,” Journal of Clinical Investigation, vol. 76, no. 5, pp. 1913–1920, 1985. View at Google Scholar · View at Scopus
  10. G. M. Blake, V. J. Lewington, M. A. Zivanovic, and D. M. Ackery, “Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidine,” European Journal of Nuclear Medicine, vol. 15, no. 9, pp. 618–623, 1989. View at Google Scholar · View at Scopus
  11. H. J. Verberne, D. O. Verschure, G. A. Somsen, B. L. F. Van Eck-Smit, and A. F. Jacobson, “Vascular time-activity variation in patients undergoing 123I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 6, pp. 1132–1138, 2011. View at Publisher · View at Google Scholar
  12. D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976. View at Google Scholar · View at Scopus
  13. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Google Scholar
  14. C. Tomson, S. Blades, R. Burden et al., “Chronic Kidney Disease in Adults. In: UK Guidelines for Identification, Management and Referral,” 2009.
  15. H. J. Verberne, C. Feenstra, W. M. De Jong, G. A. Somsen, B. L. F. Van Eck-Smit, and E. B. Sokole, “Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 9, pp. 1100–1107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Agostini, I. Carrio, and H. J. Verberne, “How to use myocardial 123I-MIBG scintigraphy in chronic heart failure,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 4, pp. 555–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. C. Kline, D. P. Swanson, and D. M. Wieland, “Myocardial imaging in man with I-123 meta-iodobenzylguanidine,” Journal of Nuclear Medicine, vol. 22, no. 2, pp. 129–132, 1981. View at Google Scholar · View at Scopus
  18. H. J. Verberne, E. Busemann Sokole, A. F. van Moerkerken et al., “Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 4, pp. 798–807, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. D. Aaronson, J. S. Schwartz, T. M. Chen, K. L. Wong, J. E. Goin, and D. M. Mancini, “Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation,” Circulation, vol. 95, no. 12, pp. 2660–2667, 1997. View at Google Scholar · View at Scopus
  20. J. M. Flack, J. D. Neaton, B. Daniels, and P. Esunge, “Ethnicity and renal disease: lessons from the multiple risk factor intervention trial and the treatment of mild hypertension study,” American Journal of Kidney Diseases, vol. 21, no. 4, pp. 31–40, 1993. View at Google Scholar · View at Scopus
  21. A. Al-Ahmad, W. M. Rand, G. Manjunath et al., “Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction,” Journal of the American College of Cardiology, vol. 38, no. 4, pp. 955–962, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. N. G. Mahon, E. H. Blackstone, G. S. Francis, R. C. Starling, J. B. Young, and M. S. Lauer, “The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure,” Journal of the American College of Cardiology, vol. 40, no. 6, pp. 1106–1113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. T. Kearney, K. A. A. Fox, A. J. Lee et al., “Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure,” Journal of the American College of Cardiology, vol. 40, no. 10, pp. 1801–1808, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. W. M. McClellan, W. D. Flanders, R. D. Langston, C. Jurkovitz, and R. Presley, “Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study,” Journal of the American Society of Nephrology, vol. 13, no. 7, pp. 1928–1936, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. F. A. McAlister, J. Ezekowitz, M. Tonelli, and P. W. Armstrong, “Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study,” Circulation, vol. 109, no. 8, pp. 1004–1009, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Agostini, H. J. Verberne, W. Burchert et al., “I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 3, pp. 535–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Opasich, L. Tavazzi, D. Lucci et al., “Comparison of one-year outcome in women versus men with chronic congestive heart failure,” American Journal of Cardiology, vol. 86, no. 3, pp. 353–357, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. S. A. Hunt, W. T. Abraham, M. H. Chin et al., “ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the,” Circulation., vol. 112, no. 12, pp. e154–e235, 2005. View at Google Scholar
  29. K. Dickstein, A. Cohen-Solal, G. Filippatos et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008,” European Heart Journal, vol. 29, no. 19, pp. 2388–2442, 2008. View at Publisher · View at Google Scholar